Photoacoustic mediated multifunctional tumor antigen trapping nanoparticles inhibit the recurrence and metastasis of ovarian cancer by enhancing tumor immunogenicity.
Photoacoustic mediated multifunctional tumor antigen trapping nanoparticles inhibit the recurrence and metastasis of ovarian cancer by enhancing tumor immunogenicity.
复制标题
光声介导的多功能肿瘤抗原捕获纳米颗粒通过增强肿瘤免疫原性抑制卵巢癌复发和转移。
DOI:
10.1186/s12951-022-01682-5
复制
发表时间:
2022-11-03
影响因子:
10.2
通讯作者:
Chang S
中科院分区:
文献类型:
--
作者:
Zhong X;Li C;Zhao G;Li M;Chen S;Cao Y;Wang Q;Sun J;Zhu S;Chang S
The hypoimmunogenicity of tumors is one of the main bottlenecks of cancer immunotherapy. Enhancing tumor immunogenicity can improve the efficacy of tumor immunotherapy by increasing antigen exposure and presentation, and establishing an inflammatory microenvironment. Here, a multifunctional antigen trapping nanoparticle with indocyanine green (ICG), aluminum hydroxide (Al(OH)3) and oxaliplatin (OXA) (PPIAO) has been developed for tumor photoacoustic/ultrasound dual-modality imaging and therapy. The combination of photothermal/photodynamic therapy and chemotherapy induced tumor antigen exposure and release through immunogenic death of tumor cells. A timely capture and storage of antigens by aluminum hydroxide enabled dendritic cells to recognize and present those antigens spatiotemporally. In an ovarian tumor model, the photoacoustic-mediated PPIAO NPs combination therapy achieved a transition from “cold tumor” to “hot tumor” that promoted more CD8+ T lymphocytes activation in vivo and intratumoral infiltration, and successfully inhibited the growth of primary and metastatic tumors. An in situ tumor vaccine effect was produced from the treated tumor tissue, assisting mice against the recurrence of tumor cells. This study provided a simple and effective personalized tumor vaccine strategy for better treatment of metastatic and recurrent tumors. The developed multifunctional tumor antigen trapping nanoparticles may be a promising nanoplatform for integrating multimodal imaging monitoring, tumor treatment, and tumor vaccine immunotherapy. The online version contains supplementary material available at 10.1186/s12951-022-01682-5.
登录
查看更多内容
影响因子:
9
作者:
Fucikova J;Kepp O;Kasikova L;Petroni G;Yamazaki T;Liu P;Zhao L;Spisek R;Kroemer G;Galluzzi L
通讯作者:
Galluzzi L
DOI:
10.1016/j.jconrel.2013.10.032
发表时间:
2014-01-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Li X;Aldayel AM;Cui Z
通讯作者:
Cui Z
影响因子:
64.8
作者:
通讯作者:
--
DOI:
10.1126/science.aaa3828
发表时间:
2015-05-15
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Carreno BM;Magrini V;Becker-Hapak M;Kaabinejadian S;Hundal J;Petti AA;Ly A;Lie WR;Hildebrand WH;Mardis ER;Linette GP
通讯作者:
Linette GP
影响因子:
5.5
作者:
Colaprico, Annalisa;Senesi, Silvia;O'Hagan, Derek T.
通讯作者:
O'Hagan, Derek T.